Adult stem cells extracted during liposuction can be used to grow healthy new small-diameter blood vessels for use in heart bypass surgery and other procedures, according to new research presented at the American Heart Association's Basic Cardiovascular Sciences 2012 Scientific Sessions.
Rehrig Pacific Company, a market leader in reusable transport packaging, environmental waste & recycling collection containers, asset management & tracking solutions, reverse logistics, as well as packaging & container recovery services, introduces Rehrig Healthcare System’s Sharps Tank, an FDA 510(k) cleared, 17 gallon reusable sharps container.
Sound Surgical Technologies, a Colorado-based company that prides itself on a solid reputation for high quality, effective body shaping products and reliable service, announced the launch of VASERsmooth, the latest minimally invasive cellulite solution to hit the aesthetic market.
How are you influencing implantable devices?
NORTHWOOD, Ohio--(BUSINESS WIRE)--Jul 23, 2012--NAMSA, the world’s leading medical device research organization, has acquired The Integra Group, a preclinical and clinical research organization located near Minneapolis. The medical device research, regulatory approval and commercialization...
SAN DIEGO, July 20, 2012 /- UBM Canon is pleased to announce the return of the MEDevice Forum San Diego . The two-day event will be held from Wednesday, September 19 - Thursday, September 20 at The San Diego Convention Center. (Photo: http://photos.prnewswire.com/prnh/20120720/LA43844-a ) (Logo: http://photos.prnewswire.com/prnh/20120720/LA43844LOGO-b ) (Logo: http://pho...
A study showing that surgery for prostate cancer is unnecessary sends shares of Intuitive Surgical down another 8% today. Wall Street investors are taking another bite out of Intuitive Surgical (NSDQ:ISRG) today, sending its share price down nearly 8% on a study showing that prostate surgery is un-necessary for many men. ISRG shares dropped fast on Wall Street yesterday afternoon, fueled by the study and soft prostatectomy procedure volumes.
Mazor Robotics wins FDA clearance to extend its Renaissance robotic platform into brain surgery. Mazor Robotics (PINK:MZRTF) won FDA clearance extending use of its Renaissance robotic system into brain surgery, the company announced this week.
The FDA scientist behind allegations of in-house surveillance and overlooked safety concerns at the federal watchdog agency is no stranger to lawsuits. One of the whistle-blowing scientists who accused the FDA of persecuting and spying on employees has a few lawsuits under his belt, a charge that may damage his credibility in an ongoing case against the federal watchdog agency. Radiologist Dr. Robert Smith, a member of the so-called "FDA 9," joined colleagues in suing the FDA and its leadership for alleged retaliation against them when they raised questions agency decisions about some mammogram and colonoscopy systems.
The FDA clears Cynosure's home anti-wrinkle device for over-the-counter sales. Aesthetic devices maker Cynosure (NSDQ:CYNO) won FDA clearance for its home-use anti-facial wrinkle device, the company reported today. Developed in conjunction with consumer goods maker Unilever (NYSE:UL), the as-yet-unnamed device was cleared for over-the-counter sales in the U.S.
Chances are, you know someone who has been diagnosed with cancer. One out of every three women will contract the disease in their lifetime; for men the odds are even greater. Now, an exciting new protocol has received approval from the FDA and WIRB (Western Institutional Review Board)...
DUBLIN--(BUSINESS WIRE)--Jul 19, 2012--Research and Markets ( http://www.researchandmarkets.com/research/mh5btk/roche_diagnostics ) has announced the addition of the "Roche Diagnostics Medical Device Company Intelligence Report" company profile to their offering. Headquartered in Basel,...
Hospital Intensive Care Unit (ICU) objects made from antimicrobial copper harbor 83% less bacteria on average, compared to stainless steel, plastic, and wood touch surfaces, according to a recently published study in the Journal of Clinical Microbiology.
The worldwide in vitro diagnostic (IVD) market broke $50 billion last year on the strength of an aging population, product innovations and sales to emerging markets, according to Kalorama Information. The healthcare market research publisher revealed its finding, which will be included in the upcoming report to be published later this month, The Worldwide Market for In Vitro Diagnostic (IVD) Tests, 8th Edition.
No more painful dental injections. That would be music to the ears of millions of people in the U.S. and around the world who fear going to the dentist. According to studies from the Dental Fears Research Clinic at the University of Washington Dental School in Seattle, upwards of 50 million Americans avoid the dentist due to their fear of pain. Most often, it’s the pain associated with dreaded dental injections. The fact is that dentistry itself doesn’t hurt – injections do.
Growing concerns about hospital acquired infections (HAIs) are driving the demand for disposable needles and syringes, according to a new report by healthcare experts GBI Research. The new report* states that demand for disposable hospital supplies is growing across the world, as they reduce risks of cross-contamination. The globally swelling diabetes population, and increasing numbers with access to state healthcare coverage mean that more and more patients will face the risk of infection through hospital contagion.
SynCardia Systems, Inc., manufacturer of the world’s first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that Harvard-affiliated Brigham and Women’s Hospital in Boston has performed New England’s first implant of the SynCardia temporary Total Artificial Heart.
Cohera Medical, Inc.®, a leading innovator and developer of absorbable surgical adhesives and sealants, today announced the start of a no-drain clinical trial in 30 patients at two prominent surgery centers in Germany. The study will investigate the safety and effectiveness of TissuGlu® Surgical Adhesive...
The neurostimulation devices market can expect impressive gains over the next few years, as the global number of individuals with neurological conditions continues to rise, states a new report by healthcare experts GBI Research.
Historically, surgical technology has been characterized as relatively conservative with low levels of innovation. With a number of ground-breaking developments, no longer is this the case. One particularly interesting area that has advanced recently is the field of 3D endoscopy, where visualization technology is transforming the tools available to surgeons and the effectiveness of their procedures. This, together with some of the other visualization technologies being developed, puts us on the brink of a technology revolution within the surgical device arena.
DSM, a global leader in biomedical materials, today announced that its VitroStealth® non-biofouling coating is used in Afinion®, Axis-Shield’s next generation point-of-care diagnostic system. Physicians can use Afinion® during the span of an office visit and obtain patient lipid levels within a matter of minutes.
An automated tissue and brain tumor removal device has been approved for use in New Zealand, possibly impacting the estimated 250 primary and 1,500 secondary brain tumors diagnosed every year in the country.
Healthcare Supply Chain Association (HSCA) President Curtis Rooney today released the following statement regarding FDA’s release of a proposed rule on a Uniform Device Identifier (UDI) for implantable medical devices...
The U.S. Food and Drug Administration (FDA) has granted Cook Medical 510(k) clearance for the Evolution® Colonic Controlled-Release Stent, Cook announced today. The new stent expands Cook's line of Evolution controlled-release stents...